Welcome to our dedicated page for TRSSF news (Ticker: TRSSF), a resource for investors and traders seeking the latest updates and insights on TRSSF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect TRSSF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of TRSSF's position in the market.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Tyson 2.0, co-founded by Mike Tyson, has successfully closed a $9 million Series A funding round, led by JW Asset Management. The company, which has become a popular cannabis brand across 20 U.S. states and Canada, has sold over 4,000 pounds of cannabis flower. The funds will be instrumental in acquiring celebrity intellectual properties, enhancing marketing, and expanding distribution. Additionally, Nicole Cosby has been appointed as the Chief Legal and Licensing Officer. Tyson 2.0 aims to capitalize on the growing demand for celebrity-backed cannabis products.
TerrAscend Corp. (TRSSF) reported Q1 2022 net sales of $49.7 million, a slight increase from $49.2 million in Q4 2021, but a decrease of 7% year-over-year. Gross profit margin fell to 30.5% from 42.3% in the previous quarter, with adjusted EBITDA dropping to $3.3 million from $11.9 million. The company experienced challenges due to a vape recall in Pennsylvania and increased costs in New Jersey ahead of adult sales. However, it remains optimistic for Q2, expecting improved revenue and margins, supported by strategic acquisitions and market growth.